Akebia Therapeutics, Inc.
2019 Q4 - 2025 Q4 (15 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 194 | 0.0% | 120,398 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 326 | 0.0% | 89,677 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 142 | 0.0% | 73,810 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 144 | 0.0% | 75,617 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 104 | 0.0% | 78,444 | 9/30/2024 |
| 2022 Q1 | 8/11/2023 | 57 | 0.0% | 78,736 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 224 | 0.0% | 98,948 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 296 | 0.0% | 102,890 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 360 | 0.0% | 94,950 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 300 | 0.0% | 88,665 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 253 | 0.0% | 90,451 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 204 | 0.0% | 81,345 | 9/30/2020 |
| 2020 Q2 | 8/10/2020 | 984 | 0.0% | 77,476 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 575 | 0.0% | 75,862 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 455 | 0.0% | 71,929 | 12/31/2019 |